News

'Superbabies' Startup Seeks Funds for Controversial Gene Editing Push

By Sophie Alexander and Ike Swetlitz, Bloomberg | 06.25.2025

A California-startup focused on genetically editing human embryos — a step toward creating so-called designer babies — is raising money as many of Silicon Valley’s ultra-rich turn their attention to one of the most controversial technologies in medicine.

Bootstrap Bio...

Patents & Other IP

Can doctors test embryos for autism? And should they?

By Brittany Luse, Liam McBain, and Neena Pathak, NPR [cites CGS' Katie Hasson] | 05.28.2025

A newly available kind of genetic testing, called polygenic embryo screening, promises to screen for conditions that can include cancer, obesity, autism, bipolar disorder, even celiac disease. These conditions are informed by many genetic variants and environmental factors - so...

Genetic Selection

Why Deleting Your 23andMe Data Is a Political Imperative

By Katie Sagaser, The DNA Exchange | 05.27.2025

Disclaimer: The views and opinions expressed in this piece are solely my own and do not represent those of my...

U.S. Federal

Trumpian “Common Sense” and the History of IQ Tests

By Pepper Stetler, Los Angeles Review of Books | 05.08.2025

^{"Donald Trump Signs The Pledge" by Michael Vadon

is licensed under CC BY-SA 2.0.}

This is...

Society

Genetic Testing ‘Strongly Recommended’ For Kids With Intellectual Disability

By Michelle Diament , Disability Scoop | 07.30.2021

A new recommendation from a leading medical association is urging children with intellectual disability, developmental delay and other congenital anomalies...

Disability Rights

The nature (and nurture) of IQ

By Meredith Wadman, Science | 07.30.2021

^{Photo of Iowa Soldiers' Orphans' Home licensed for use by CC BY-SA 3.0}

In July 1934, psychologist Harold Skeels evaluated...

Bioethics

diverse national flags arranged in the shape of the globe

Inclusivity and diversity: Integrating international perspectives on stem cell challenges and potential

By Robin Fears et al., Stem Cell Reports | 07.29.2021

Introduction

Scientific advances in regenerative medicine continue to offer great promise in our attempts to tackle intractable diseases, including those...

Stem Cells

Universities should not offer the false hope of ‘fertility’ benefits

By Pamela Mahoney Tsigdinos, Times Higher Education | 07.29.2021

Talented young women and men in both the academic and business worlds share a common dilemma: their career development timeline...

U.S. Federal

Black and white photo of Henrietta Lacks

Family of Henrietta Lacks hires star civil rights attorney Ben Crump, who says they plan to sue pharmaceutical companies

By Tim Prudente, The Baltimore Sun | 07.29.2021

The family of Henrietta Lacks has hired a prominent civil rights attorney who says he plans to seek compensation for...

Biotech & Pharma

ACMG Carrier Screening Guidelines: Falling Short On Equity and Inclusion

By Katie Stoll and Robert Resta, The DNA Exchange | 07.26.2021

The American College of Medical Genetics and Genomics (ACMG) recently published a new Clinical Practice Resource that they proclaim recommends...

Genomics

IPO Raises $304M for Caribou, Developer of Gene-Edited Cell Therapies

By Alex Philippidis, Genetic Engineering & Biotechnology News | 07.26.2021

Caribou Biosciences, the developer of gene-edited cell therapies co-founded by Nobel laureate Jennifer Doudna, PhD, has launched an upsized initial...

Human Genetic Modification

Philippines approves GMO golden rice for commercial production

By Staff, GMWatch | 07.23.2021

The Philippines has approved GMO golden rice for commercial production. This is in spite of the fact that no independent...

Society